The Future Of Nano Technology
- Alan Watts
- Anti-Aging Medicine
- David Sinclair
- Gene Medicine
- Gene therapy
- Genetic Medicine
- Genetic Therapy
- Global News Feed
- Hormone Replacement Therapy
- Human Genetic Engineering
- Human Reproduction
- Integrative Medicine
- Life Skills
- Longevity Medicine
- Machine Learning
- Medical School
- Nano Medicine
- Parkinson's disease
- Quantum Computing
- Regenerative Medicine
- Stem Cell Therapy
- Stem Cells
- Want to look better on your next Zoom call? Skin spa helps make sense of all the options out there – KPRC Click2Houston
- Two Pitt Faculty Members Inducted into National Academy of Medicine for Work on Aging and Neuro-Rehab – Newswise
- Franz Skincare USA Announces Second Consecutive Win of "Top Skincare Face Mask" in the 2020 Aesthetic Everything Aesthetic and Cosmetic…
- Dr. Kathryn Alcarez Joins The Exclusive Haute Beauty Network Representing The Medspa Category – PR Web
- Senior Horses and Living the Good Life The Horse – TheHorse.com
- Grab Pay Philippines
- GrabPay Philippines
- GrabPay Vietnam
- rajiv joshi ibm
- AI Trained on the Bible Spits Out Bleak Religious Prophecies
- hope frozem
- benchtop bioreactor market
- world economic forum how chemical industry boost stimulus
- are mushrooms the future of well ess
- Fururism this x ray map of the entire sky is
|Search Immortality Topics:|
Category Archives: Biochemistry
CHELMSFORD, Mass., Oct. 16, 2020 /PRNewswire/ --Brooks Automation, Inc. (Nasdaq: BRKS) announced today that Dr. Amy Liao, president of Brooks Life Science Services, has received the Biomedical Engineering Society's Wallace A. Coulter award for innovation in healthcare. The Coulter award recognizes an outstanding individual who has demonstrated a lifetime commitment to and made important contributions to patient healthcare. Dr. Liao will be speaking at the plenary session of the 2020 Biomedical Engineering Society's virtual meeting on Friday October 16, 2020.
"We are very proud to see Amy recognized by the Biomedical Engineering Society with this award," commented Steve Schwartz, CEO and president of Brooks Automation. "Amy's accomplishments with over 20 years in the field of genomics has led to breakthrough innovations in gene sequencing and gene synthesis, and in GENEWIZ, she built a company that has supported thousands of customers in their pursuit of scientific discoveries. All of us at Brooks congratulate Amy for this recognition of her achievements."
Dr. Amy Liao was appointed President of Brooks Life Sciences Services in April 2020. She joined Brooks in November 2018 following its acquisition of GENEWIZ, a global provider of genomics services, which she co-founded in 1999. Dr. Liao held various leadership positions during her tenure at GENEWIZ culminating in her appointment as Chief Executive Officer in January 2017. Dr. Liao received her Ph.D. in Biochemistry and Cell Biology from SUNY Stony Brook. She did her post doctorate studies at Columbia University before leaving to found GENEWIZ. She holds a B.S. in Biochemistry from Nankai University, China and an M.S. in Biochemistry from Tsinghua University, China.
About Brooks AutomationBrooks (Nasdaq: BRKS) is a leading provider of life science sample-based solutions and semiconductor manufacturing solutions worldwide. The Company's Life Sciences business provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Brooks Life Sciences' GENEWIZ division is a leading provider of DNA gene sequencing and gene synthesis services. With over 40 years as a partner to the semiconductor manufacturing industry, Brooks is a provider of industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, visit http://www.brooks.com.
INVESTOR and MEDIA CONTACT:
Mark NamaroffDirector, Investor RelationsBrooks Automation 978.262.2635[emailprotected]
SOURCE Brooks Automation
Global Biochemical Reagents Market Offered in New Research Forecasted through 2025 – Express Journal
Growth Forecast Report on Biochemical Reagents Market Size | Industry Segment by Applications (Hospitals, Diagnostic centers and Academics and Research), by Type (Polymerase chain reaction (PCR) reagent kits, Cell and tissue culture reagents, Electrophoresis reagents, Chromatography reagents and Others), Regional Outlook, Market Demand, Latest Trends, Biochemical Reagents Industry Share & Revenue by Manufacturers, Company Profiles, Growth Forecasts to 2025. Analyzes current market size and upcoming 5 years growth of this industry.
The research report on Biochemical Reagents market report consists of a thorough assessment of this industry domain. As per the study, the market is expected to acquire notable returns and showcase a healthy growth rate during the forecast period.
The document investigates the major industry trends and elaborates on the volume of sales, market size, growth opportunities, and revenue estimations. The report provides a succinct analysis of growth avenues and also elaborates market segmentations.
Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/224585
Also, the research report evaluates the impact of COVID-19 pandemic on the growth propellers of the Biochemical Reagents market.
Other takeaways of the Biochemical Reagents market report:
As per the regional analysis of the Biochemical Reagents market:
The report comprises of a granular analysis of the geographical landscape of the Biochemical Reagents market and divides the same into:
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biochemical Reagents Industry product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biochemical Reagents market, with price, sales, revenue and global market share of Biochemical Reagents Industry in 2018 and 2019.
Chapter 3, the Biochemical Reagents market competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biochemical Reagents market breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biochemical Reagents market forecast, by regions, purity and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biochemical Reagents market sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Request Customization on This Report @ https://www.express-journal.com/request-for-customization/224585
COVID-19 Impact ON Biochemical Reagent Market Manufacturers Analysis And Industry Insights 2020-2026 | Thermo Fisher Scientific, Beckman Coulter,…
Global Biochemical Reagent market forecast 2020-2026 tracks the latest market dynamics, such as driving factors, restraining factors, and industry news like mergers, acquisitions, and investments. It provides market size (value and volume), market share, growth rate by types, applications, and combines both qualitative and quantitative methods to make micro and macro forecasts in different regions or countries.
The Biochemical Reagent market size reports can help to understand the market and strategize for business expansion accordingly. In the strategy analysis, it gives insights from marketing channel and market positioning to potential growth strategies, providing in-depth analysis for new entrants or exists competitors in the Biochemical Reagent market industry.
Get a Sample Copy of the report:https://www.reporthive.com/request_sample/2469931
Major players covered in this report:
Thermo Fisher ScientificBeckman CoulterAbbottMerck & Co., Inc.Life TechnologiesBio-RadWater CorporationSigma-AldrichAgilent Technologies Inc.Betcon DickinsonRocheAB AnaliticaGesan ProductionMedicalsystem Biotechnology Co., Ltd.PromegaPZ CorAugustSENTINEL CH.Teco DiagnosticsDickinson & Company
Biochemical Reagent market by Types:
Chromatography ReagentsElectrophoresis ReagentsMass SpectrometryPCR Reagent KitsCell and Tissue Culture Reagents
Biochemical Reagent market by Applications:
Protein Synthesis and PurificationGene ExpressionDNA and RNA AnalysisDrug Testing
Inquire or share your questions if any before the purchasing this report @https://www.reporthive.com/request_customization/2469931
Geographically, the regional consumption and value analysis by types, applications, and countries are included in the report. Furthermore, it also introduces the major competitive players in these regions.
Major regions covered in the report:-North America-Europe-Asia-Pacific-Latin America-Middle East & Africa
Detailed TOC of Global Biochemical Reagent market:1 Market Overview1.1Biochemical Reagent market Introduction1.2 Market Analysis by Type1.2.1 Type 11.2.2 Type 21.3 Market Analysis by Application1.3.1 Application 11.3.2 Application 21.4 Market Analysis by Region1.4.1 United States Market States and Outlook (2014-2026F)1.4.2 Europe Market States and Outlook (2014-2026F)1.4.3 China Market States and Outlook (2014-2026F)1.4.4 Japan Market States and Outlook (2014-2026F)1.4.5 Southeast Asia Market States and Outlook (2014-2026F)1.5 Market Dynamics and Development1.5.1 Merger, Acquisition and New Investment1.5.2 Market SWOT Analysis1.5.3 Drivers1.5.4 Limitations1.5.5 Opportunities and Development Trends1.6 Global Market Size Analysis from 2014 to 20261.6.1 Global Market Size Analysis from 2014 to 2026 by Consumption Volume1.6.2 Global Market Size Analysis from 2014 to 2026 by Value1.6.3 Global Price Trends Analysis from 2014 to 20262 Global Biochemical Reagent market Competition by Types, Applications, and Top Regions and Countries2.1 Global Biochemical Reagent market(Volume and Value) by Type2.1.1 Global Biochemical Reagent market Consumption and Market Share by Type (2014-2019)2.1.2 Global Biochemical Reagent market Revenue and Market Share by Type (2014-2019)2.2 Global Biochemical Reagent market(Volume and Value) by Application2.2.1 Global Biochemical Reagent market Consumption and Market Share by Application (2014-2019)2.2.2 Global Biochemical Reagent market Revenue and Market Share by Application (2014-2019)2.3 Global Biochemical Reagent market(Volume and Value) by Region2.3.1 Global Biochemical Reagent market Consumption and Market Share by Region (2014-2019)2.3.2 Global Biochemical Reagent market Revenue and Market Share by Region (2014-2019)
Our research base consists of a wide spectrum of premium market research reports. Apart from comprehensive syndicated research reports, our in-house team of research analysts leverages excellent research capabilities to deliver highly customized tailor-made reports. The market entry strategies presented in our reports has helped organizations of all sizes to generate profits by making timely business decisions. The research information including market size, sales, revenue, and competitive analysis offered, is the product of our excellence in the market research domain.
After being diagnosed with ulcerative colitis at seven years old, one local teenager is happily in remission after years of treatment.
The journey to get to that point wasn't an easy one and required help from many sources.
Kalena needed specialized treatment that included attending at BC Children's Hospital several times a year.
Kathy Samaai, Kalena's mom, said it was a scary time for the family when Kalena was first diagnosed on her seventh birthday.
Ulcerative colitis is rarely diagnosed in someone her age.
The trouble started about six months before the diagnosis when Kalena started getting fevers for no apparent reason. She was in pain and began having bloody stool that prompted her family to take her to the local emergency room on a regular bases.
Kalena was only six years old and needed specialized tests like an endoscopy and a colonoscopy.
Those procedures are not done in Prince George in children and the she needed to go to Vancouver.
"Its a 12-hour drive, Samaai said. Our car wasnt new and I was working full time and worried about missing work.
Once diagnosed the proposed treatment options were not ideal and while one involved an invasive surgery that involved installing a stoma bag that sits outside the body, the other was a biochemical infusion that comes with risk of side effects.
"Kalena always liked to swim, especially synchronized swimming and just loves the water so wearing a bag was not ideal," Samaai said.
As a family it was decided that the biochemical infusions would be used for treatment, as long as Kalena's system would accept it.
"But of course with the biochemical comes side effects like a sensitivity to sun, for example," Samaai said. "So she had to stay out of the sun or cover up really well to avoid burning because that could lead to cancer."
The treatment was administered at BC Children's Hospital and would continue every eight weeks for the foreseeable future.
The trips by car down south were all right until winter hit and that was when hospital staff told Samaai about Hope Air to help with flights to and from treatments.
When I called Hope Air it was a good experience, Samaai said, The staff was easy to connect with and our flight was booked. That was in 2012 and we have been flying with Hope Air ever since. We just couldnt have done it without Hope Air.
Before that first trip. Kalena had never even been on a plane. She and her mother have made 75 trips with Hope Air to date.
Kalena is now 16, currently in remission and feeling good.
She is a volleyball player and a swimmer working on getting her lifeguard certification. Kalena wants to go into medicine when she's older and once the coronavirus pandemic is over she looks forward to life guarding to earn money for her tuition.
Read the original post:
Teen on the mend after colitis battle - Prince George Citizen
Rutgers Awarded $5 Million Grant from NIH to Improve Access to COVID-19 Testing within Underserved and Vulnerable Communities – Rutgers Today
The award is part of the RADx Underserved Populations (RADx-UP) program in the Rapid Acceleration of Diagnostics (RADx) initiative
The New Jersey Alliance for Clinical and Translational Science (NJ ACTS) at Rutgers University received a $5 million National Institutes of Health grant to launch outreach campaigns and expand access to COVID-19 testing for underserved and vulnerable communities in New Jersey.
The grant will fund a Rutgers-led study called the New Jersey Healthcare Essential WoRker Outreach and Education Study - Testing Overlooked Occupations, or NJ HEROES TOO, under the NIHs Rapid Acceleration of Diagnostics (RADx) initiative, RADx Underserved Populations (RADx-UP) program. The program supports research that aims to better understand COVID-19 testing patterns among underserved and vulnerable populations; strengthen the data on disparities in infection rates, disease progression and outcomes; and develop strategies to reduce the disparities in COVID-19 testing.
NJ HEROES TOO focuses on the Black and Latinx communities disproportionately affected by COVID-19 in places where Rutgers academic medical centers are deeply rooted. NJ ACTS partnered with community and health care organizations in Essex, Middlesex, Passaic and Union counties to co-design this study.
Medical sociologist and lead principal investigator for the study, Shawna Hudson, who is also co-director of Community Engagement forNJ ACTS, reflected that much of the public attention with frontline health care heroes has been focused on doctors and nurses. NJ HEROES TOO focuses on vulnerable health care workers and their families, including home health and personal care aides, maintenance staff, housekeeping, and hospital security, groups which are largely Black and Latinx and have concerns about exposing their families, friends and communities.
This is an incredible opportunity to improve COVID-19 awareness in vulnerable individuals across NJ. Its a game changer, said Reynold Panettieri, director of NJ ACTS.
Rutgers is one of 32 institutions that received an NIH award through the RADx-UP program to support projects designed to rapidly implement COVID-19 testing strategies in populations disproportionately affected by the pandemic. These groups include African Americans, American Indians/Alaskan Natives, Latinos/Latinas, Native Hawaiians, older adults, pregnant women, and those who are homeless or incarcerated.
It is critical that all Americans have access to rapid, accurate diagnostics for COVID-19, especially underserved and vulnerable populations who are bearing the brunt of this disease, said NIH director Francis S. Collins. The RADx-UP program will help us better understand and alleviate the barriers to testing for those most vulnerable and reduce the burden of this disease.
Rutgers researchers are also working with community organizations to understand the best way of communicating the importance of being tested and facilitating COVID-19 at-home saliva self-testing.
We need to recognize the disparities for Black and Latinx communities. To help address inequities, it is critical that we use an on-the-ground approach by partnering with community members whom they know and trust. We need to ensure that the people and families who need testing and treatment are detected earlier and get help earlier, added Manny Jimnez,a study principal investigator and director of developmental and behavioral pediatrics education at the Boggs Center on Developmental Disabilities at Rutgers Robert Wood Johnson Medical School.
NJ HEROES TOO will be developed in two phases. The first phase includes an evaluation process involving stakeholder interviews, evidence-based content review, pilot testing, and stakeholder input to inform design and implementation of outreach strategies. The second phase will examine the impact of the studys outreach strategies on health care workers, their family members and the broader community.
The study brings together researchers, health care and community partners in a collaborative effort, and is led by the following six principal investigators:
Health care and community organizations participating include: Parker Health Group; Visiting Nurse Association Health Group; ASPIRA Association; Central Jersey Family Health Consortium, Inc.; East Orange Senior Volunteer Corporation; Health Coalition of Passaic County; Mobile Family Success Center; New Brunswick Area Branch NAACP; New Brunswick Tomorrow; New Hope NOW Community Development Corporation; Partnership for Maternal and Child Health of Northern New Jersey; Program for Parents; Puerto Rican Action Board (PRAB); The Bridge; Township of Hillside Senior Recreation Center; United Way of Greater Union County; and Urban League of Union County.
Scott M. Coyle, a University of WisconsinMadison assistant professor of biochemistry, has been named a 2020 Packard Foundation Fellow in Science and Engineering.
Coyle, whose research focuses on understanding and engineering microscale molecular and cellular machines, is one of 20 early career scientists from across the United States to be awarded this years Packard Fellowship. The fellowship provides $875,000 in flexible funding over five years.
Scott Coyles research could have could have far-reaching applications, from expanding the scope and utility of cell-based therapies deployed inside the human body to fight human disease to developing smart micro-technologies that could scavenge damaged environmental sites to be used for bioremediation. Photo by Robin Davies
Coyles project will develop models for how the structure and behavior of single cells which he likens to microscopic robots that move through, interact with, and respond to their environment are encoded and programmed by their smaller components: themotors, filaments, signaling molecules, and so on that that are used to build and control the physical machinery of the cell. His goal is to reveal strategies for building and organizing molecules into complex machines that scientists can one day use to engineer new cell behaviors.
What Coyle learns could have far-reaching applications, from expanding the scope and utility of cell-based therapies deployed inside the human body to fight human disease to developing smart micro-technologies that could scavenge damaged environmental sites to be used for bioremediation. The work could even lead to potential computing systems powered by biochemistry instead of electricity.
To do this we explore a broad range of cellular systems, says Coyle, from human cells that crawl around your body to single celled protozoans that can jump, forage, and hunt for prey like tiny animals. Despite how different these cells appear, they are all built from a similar toolbox of molecular components, but ones which are deployed in different ways not so unlike how you can make a whole bunch of different electronic devices out of resistors, capacitors and transistors.
Coyle was drawn to apply for the fellowship in part because of its support of collaborative and creative approaches to research. The Packard Fellowships flexible funding allows scientists the freedom to pursue research in innovative ways. In Coyles case, this flexibility provides the resources for his lab to obtain and work with materials and biological systems, such as protozoan cells, which may otherwise be difficult to secure with traditional funding streams.
Dr. Coyle is an extraordinary young scientist with a rich array of academic and industry research experiences, says Brian Fox, associate vice chancellor for research policy and integrityand biochemistry department chair. He is uniquely poised to integrate his training and break new ground with an exciting research program that will redefine how we understand the systems biology of cell behavior.
For Coyle, the fellowship is about a big-picture research vision. Collaboration and innovation will drive Coyles project, as he works with researchers across disciplines at UWMadison, including computer science for technologies in machine vision and deep learning as applied to cell biology and limnology to study Madisons lakes, a source of myriad understudied protozoan cells.
We are entering an era in which the extraordinary biology of living systems will provide us a foundation upon which to build an exciting new class of molecular technologies, says Coyle. Getting to interact with physicists, ecologists and engineers will provide invaluable new perspectives and help me approach my own research questions from a fresh and inspired point of view.
Coyle is UWMadisons 16th Packard Fellowship winner, chosen from among 100 nominees from 50 universities across the country by an advisory panelof distinguished scientists and engineers.